Anesth Analg 2002;95:287-293
© 2002 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Aprotinin Versus Placebo in Major Orthopedic Surgery: A Randomized, Double-Blinded, Dose-Ranging Study
Charles Marc Samama, MD PhD*,
Olivier Langeron, MD ,
Nadia Rosencher, MD ,
Xavier Capdevila, MD PhD ,
Patricia Rouche, MD||,
Michel Pegoix, MD¶,
Josée Bernière, MD#, and
Pierre Coriat, MD for the Hémorragies et Aprotinine en Chirurgie Orthopédique Lourde Study Group
*Département dAnesthésie-Réanimation, Centre Hospitalo-Universitaire (CHU) Avicenne, Bobigny; Département dAnesthésie-Réanimation, CHU Pitié-Salpêtrière, Paris; Département dAnesthésie-Réanimation, CHU Cochin, Paris; Département dAnesthésie-Réanimation A, Hôpital Lapeyronie, CHU de Montpellier, Montpellier; ||Département dAnesthésie-Réanimation, Hôpital Saint Joseph, Paris; ¶Département dAnesthésie-Réanimation, CHU de CaenCôte de Nacre, Caen; and #Département dAnesthésie-Réanimation, CHU Trousseau, Paris, France
Address correspondence and reprint requests to Charles Marc Samama, Département dAnesthésie-Réanimation, Hôpital Avicenne 125, Route de Stalingrad, 93009 Bobigny Cedex, France. Address e-mail to cmsamama{at}invivo.edu
We conducted a prospective, multicenter, double-blinded, dose-ranging study to compare the risk/benefit ratio of large- and small-dose aprotinin with placebo after major orthopedic surgery. Fifty-eight patients were randomized into three groups: Large-Dose Aprotinin (4 M kallikrein inactivator unit [KIU] bolus before surgery followed by a continuous infusion of 1 M KIU/h until the end of surgery), Small-Dose Aprotinin (2 M KIU bolus plus 0.5 M KIU/h), and Placebo. Bleeding was measured and calculated. Bilateral ascending venography was systematically performed on the third postoperative day. Measured and calculated blood loss decreased in the Large-Dose Aprotinin group (calculated bleeding, whole blood, hematocrit 30%, median [range], 2,023 mL [6334,113] as compared with placebo, 3,577 mL [1,67021,758 mL]). The total number of homologous and autologous units was also significantly decreased in the Large-Dose Aprotinin group (2 U [05 U] as compared with placebo, 4 U [042 U]). No increase in deep vein thrombosis or pulmonary embolism was observed in the aprotinin groups. Large-dose aprotinin was safe and effective in dramatically reducing the measured and calculated bleeding and the amount of transfused red blood cell units after major orthopedic surgery.
IMPLICATIONS: Large doses of aprotinin decrease blood loss and transfusion amount in major orthopedic surgery.
This article has been cited by other articles:

|
 |

|
 |
 
F. Bakaeen, D. Rice, A. M. Correa, G. L. Walsh, A. A. Vaporciyan, J. B. Putnam, S. G. Swisher, J. A. Roth, J. Huh, D. Chu, et al.
Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis and Incidence of Complications
Ann. Thorac. Surg.,
September 1, 2007;
84(3):
982 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Veres, T. Radovits, H. Schultz, L.-n. Lin, J. Hutter, E. Weigang, Z. Szabolcs, and G. Szabo
Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass
Eur. J. Cardiothorac. Surg.,
August 1, 2007;
32(2):
340 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Royston, J. H. Levy, J. Fitch, W. Dietrich, S. C. Body, J. M. Murkin, B. D. Spiess, and A. Nadel
Full-Dose Aprotinin Use in Coronary Artery Bypass Graft Surgery: An Analysis of Perioperative Pharmacotherapy and Patient Outcomes
Anesth. Analg.,
November 1, 2006;
103(5):
1082 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Fischer and M. Steinhoff
Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries
Eur. J. Cardiothorac. Surg.,
December 1, 2005;
28(6):
801 - 804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shiga, Z. Wajima, T. Inoue, and A. Sakamoto
Aprotinin in Major Orthopedic Surgery: A Systematic Review of Randomized Controlled Trials
Anesth. Analg.,
December 1, 2005;
101(6):
1602 - 1607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kokoszka, P. Kuflik, F. Bitan, A. Casden, and M. Neuwirth
Evidence-Based Review of the Role of Aprotinin in Blood Conservation During Orthopaedic Surgery
J. Bone Joint Surg. Am.,
May 1, 2005;
87(5):
1129 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Mahdy and N. R. Webster
Perioperative systemic haemostatic agents
Br. J. Anaesth.,
December 1, 2004;
93(6):
842 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.V. Gadhinglajkar, K.G. Shyamkrishnan, R. Sreedhar, and H. Sonwalkar
Delayed thrombosis of left internal jugular vein and left subclavian vein: complication related to drainage of left superior vena cava
Interactive CardioVascular and Thoracic Surgery,
December 1, 2003;
2(4):
607 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|